Kumasi Centre for Collaborative Research   Report issue

Academic/Hospital Phase 2 Phase 3 Phase 4
Founded: Kumasi Ghana (1998)

Organization Overview

First Clinical Trial
2003
NCT00206739
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2014

Timeline

NOW
  • Now

Alternative names

Kumasi Center for Collaborative Research into Tropical Medicine, Kumasi, Ghana | Kumasi Centre for Collaborative Research in Tropical Medicine | Kumasi Centre for Collaborative Research (KCCR)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acanthocheilonemiasis (Phase 2)

Buruli Ulcer (Phase 3)

Coinfection (Phase 2)

Communicable Diseases (Phase 2)

Dipetalonema Infections (Phase 2)

Infections (Phase 3)

Malaria (Phase 4)

Malaria, Falciparum (Phase 4)

Mansonelliasis (Phase 2)

Tuberculosis (Phase 2)

Ulcer (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 5
  • # of Trial APIs: 13